Timothy L. Wiemken

Pfizer (United States) — United States

Medicine · Health Sciences

37h-index4.7kcitations269works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pneumonia and Respiratory Infections(76), Respiratory viral infections research(42), Nosocomial Infections in ICU(28), Influenza Virus Research Studies(27), Pneumocystis jirovecii pneumonia detection and treatment(24)

Publications269 total

COVID-19 Vaccination and Impact on Morbidity Among Nursing Home Residents, October 2024–January 2025: An Ecological Analysis
Journal of the American Medical Directors Association·2026Open Access
P-1603. COVID-19 Case Attack Rate Differences by Vaccination Status and Vaccine Effectiveness among US Nursing Home Residents, October 5, 2024 to January 5, 2025
Open Forum Infectious Diseases·2026Open Access
deprivateR: Calculating and Analyzing Measures of Deprivation in the United States
2025Open Access
In Patients Evaluated In The Emergency Room With Suspected Community-Acquired Pneumonia, ChatGPT 3.5 May Help Physicians With Assessments And Plans.
Norton Healthcare Medical Journal·2024· 1 citedOpen Access
SA62 Evaluating Generative Artificial Intelligence (GenAI) in Health Technology Assessment (HTA) Content Generation: A Proof-of-Concept Using Canadian Agency for Drugs and Technologies in Health (CADTH) Reimbursement Dossier Forms
Value in Health·2024Open Access
AI for Oncology Drug Data Harmonization — Amazon versus OpenAI
NEJM AI·2024· 1 cited
zippeR: Working with United States ZIP Code and ZIP Code Tabulation Area Data
2024· 1 citedOpen Access
Response to the letter to the editor regarding “Assisting the Infection Preventionist: Use of Artificial Intelligence for Healthcare-Associated Infection Surveillance”
American Journal of Infection Control·2024Open Access
Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case–Control Study
Vaccines·2024· 3 citedOpen Access
EE333 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the U.S.: An Updated Analysis
Value in Health·2024· 1 citedOpen Access
ChatGPT Generates Appropriate Assessments and Plans for Patients Evaluated in the Emergency Room With Suspected Community-Acquired Pneumonia (CAP)
2024
Using a data-driven approach to define post-COVID conditions in US electronic health record data
PLoS ONE·2024· 7 citedOpen Access
Assisting the infection preventionist: Use of artificial intelligence for health care–associated infection surveillance
American Journal of Infection Control·2024· 31 cited
Using machine learning to characterize the impact of oseltamivir on clinical failure in hospitalized patients with lower respiratory tract infection
2024Open Access
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System
Infectious Diseases and Therapy·2024· 15 citedOpen Access
Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States
Value in Health·2023· 22 citedOpen Access
EE644 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the US
Value in Health·2023· 1 cited
Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United States
Journal of Managed Care & Specialty Pharmacy·2023· 7 citedOpen Access
447. Clinical Features, Risk Factors, and Outcomes of COVID-19 in Immunocompromised Adults Hospitalized with Acute Respiratory Infection
Open Forum Infectious Diseases·2023Open Access
2364. Predictive Ability of mRNA COVID-19 Vaccines Against COVID-19 Disease Severity
Open Forum Infectious Diseases·2023Open Access
page 1 of 14Next →

Frequent Co-authors

Julio A. Ramírez(29), Paula Peyrani(24), Robert Kelley(10), Rodrigo Cavallazzi(10), Forest W. Arnold(9), José Bordón(7), Ruth Carrico(7), Francesco Blasi(7), Stefano Aliberti(7), Stephen Furmanek(6), John M. McLaughlin(5), William A. Mattingly(4), Brian E. Guinn(4), Mohamed Saad(4), Luis Jódar(4), Marcus Zervos(4), Kimbal D. Ford(4), Jeffrey F. Scherrer(4), Joanne Salas(4), Daniel F. Hoft(4)